RXSFD PPS is irrelevant to my position. My analysis is on the RXSFD product and execution. And as I am not on the RXSFD BOD and not expecting a call,, I only have opinions as stated below. I would do things differently. Sales numbers do not justify compensation since 2010. IMO.
My opinions are my own, and based on the knowledge I have acquired over the years of owning and operating businesses on a daily basis. They are my analysis and should not be interpreted as investment advice. Basically, just an analysis. NO more, No less.